Anthony H. Kong
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Head and Neck Cancer Studies 23
- Oncology 32
- HER2/EGFR in Cancer Research 18
- Peptidase Inhibition and Analysis 6
- Cancer Immunotherapy and Biomarkers 4
- Lung Cancer Research Studies 3
- Co-authors
- Hisham Mohamed Mehanna (13 shared papers)Henry Charles Kitchener (2 shared papers)Adrian L. Harris (7 shared papers)Merel Gijsen (9 shared papers)Theresa Anne Lawrie (1 shared paper)Nick P. Johnson (1 shared paper)Peter J. Parker (4 shared papers)Banafshé Larijani (4 shared papers)
- Journals
- Annals of Oncology (11 papers)Oncotarget (7 papers)Clinical Oncology (5 papers)BMJ Open (3 papers)Cancers (3 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Anthony H. Kong
69 papers receiving 3.0k citations
Anthony H. Kong's Hit Papers
Peers
Comparison fields: 5 of 105
- Otorhinolaryngology 772
- Oncology 1.1k
- Obstetrics and Gynecology 206
- Cancer Research 315
- Radiology, Nuclear Medicine and Imaging 367
Countries citing papers authored by Anthony H. Kong
This map shows the geographic impact of Anthony H. Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony H. Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony H. Kong more than expected).
Fields of papers citing papers by Anthony H. Kong
This network shows the impact of papers produced by Anthony H. Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony H. Kong. The network helps show where Anthony H. Kong may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony H. Kong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2018 | 767 |
| 2 | Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer Hit paper breakdown → | 2013 | 351 |
| 3 | 2012 | 152 | |
| 4 | 2013 | 146 | |
| 5 | 2010 | 114 | |
| 6 | 2006 | 99 | |
| 7 | 2020 | 98 | |
| 8 | 2015 | 81 | |
| 9 | 2014 | 73 | |
| 10 | 2021 | 72 | |
| 11 | 2016 | 69 | |
| 12 | 2008 | 66 | |
| 13 | 2007 | 62 | |
| 14 | 2002 | 59 | |
| 15 | 2014 | 56 | |
| 16 | 2018 | 55 | |
| 17 | 2017 | 53 | |
| 18 | 2018 | 50 | |
| 19 | 2006 | 49 | |
| 20 | 2021 | 48 |
About Anthony H. Kong
Anthony H. Kong is a scholar working on Otorhinolaryngology, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Cancer Research, having authored 75 papers that have together received 3.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (23 papers), HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Peptidase Inhibition and Analysis (6 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Otorhinolaryngology (772 citations), Oncology (1.1k citations), Obstetrics and Gynecology (206 citations), Cancer Research (315 citations) and Radiology, Nuclear Medicine and Imaging (367 citations). Anthony H. Kong has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Hisham Mohamed Mehanna, Henry Charles Kitchener, Adrian L. Harris, Merel Gijsen, Theresa Anne Lawrie, Nick P. Johnson, Peter J. Parker, Banafshé Larijani, Polly M. Edmonds and Stephen L. Hyer. Their work appears in journals such as Annals of Oncology, Oncotarget, Clinical Oncology, BMJ Open and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.